Showing results (131-140 of 136) with videos related to
Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 136 results.
Journal for Immunotherapy of Cancer|July 20, 2022
Colocalized targeting of TGF-β and PD-L1 by bintrafusp alfa elicits distinct antitumor responsesYan Lan, Tsz-Lun Yeung, Hui Huang, et al.Cell Chemical Biology|November 29, 2024
An engineered cereblon optimized for high-throughput screening and molecular glue discoveryHenry J Bailey, Jonathan Eisert, Rubina Kazi, et al.The Lancet. Haematology|December 15, 2016
Consolidation anti-CD22 fractionated radioimmunotherapy with 90Y-epratuzumab tetraxetan following R-CHOP in elderly patients with diffuse large B-cell lymphoma: a prospective, single group, phase 2 trialFrançoise Kraeber-Bodere, Amandine Pallardy, Hervé Maisonneuve, et al.European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|January 29, 2024
Autoantibody status, neuroradiological and clinical findings in children with acute cerebellitisL Quack, S Glatter, A Wegener-Panzer, et al.Journal of Medicinal Chemistry|August 2, 2019
Discovery of Evobrutinib: An Oral, Potent, and Highly Selective, Covalent Bruton's Tyrosine Kinase (BTK) Inhibitor for the Treatment of Immunological DiseasesRichard D Caldwell, Hui Qiu, Ben C Askew, et al.European Journal of Cancer (Oxford, England : 1990)|July 19, 2015
(90)Y-clivatuzumab tetraxetan with or without low-dose gemcitabine: A phase Ib study in patients with metastatic pancreatic cancer after two or more prior therapiesVincent J Picozzi, Ramesh K Ramanathan, Maeve A Lowery, et al.Pageof 14